 One of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers, reveals one of the most comprehensive analysis of breast cancer. The findings suggest that most basal-like breast tumors and ovarian tumors have similar genetic origins and potentially could be treated with the same drugs, said the study's co-leader Matthew J. Ellis, MD, PhD, the Anheuser-Busch Chair in Medical Oncology at Washington University School of Medicine ...
 One of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers, reveals one of the most comprehensive analysis of breast cancer. The findings suggest that most basal-like breast tumors and ovarian tumors have similar genetic origins and potentially could be treated with the same drugs, said the study's co-leader Matthew J. Ellis, MD, PhD, the Anheuser-Busch Chair in Medical Oncology at Washington University School of Medicine ...The Great Place for all lake forest health and fitness | island health and fitness | health and fitness blogs Health and Fitness Blog Information and News.
Tuesday, 25 September 2012
People With Deadly Breast Cancer Might Benefit From Drugs for Ovarian Tumors
 One of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers, reveals one of the most comprehensive analysis of breast cancer. The findings suggest that most basal-like breast tumors and ovarian tumors have similar genetic origins and potentially could be treated with the same drugs, said the study's co-leader Matthew J. Ellis, MD, PhD, the Anheuser-Busch Chair in Medical Oncology at Washington University School of Medicine ...
 One of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers, reveals one of the most comprehensive analysis of breast cancer. The findings suggest that most basal-like breast tumors and ovarian tumors have similar genetic origins and potentially could be treated with the same drugs, said the study's co-leader Matthew J. Ellis, MD, PhD, the Anheuser-Busch Chair in Medical Oncology at Washington University School of Medicine ...
Subscribe to:
Post Comments (Atom)
 
No comments:
Post a Comment